
Business News
Merck’s $8 billion cancer vaccine faces first U.S. jury trial
Jurors will weigh whether Merck withheld side-effect reports from drug regulators and launched misleading marketing campaigns to turn the drug into a blockbuster product. Read More
https://fortune.com/img-assets/wp-content/uploads/2025/01/GettyImages-1251776810-e1738017238996.jpg?resize=1200,600
2025-01-27 22:37:10